Suchergebnisse - "Perrone, Francesco"

PubPharm (18)

1

Assessing Financial Toxicity in Patients With Cancer : Moving Away From a One-Size-Fits-All Approach

enthalten in: Journal of oncology practice | 2019

von Perrone, F. | Di Maio, M. | Efficace, F. | +4

CommentOn: J Oncol Pract. 2019 Apr;15(4):e300-e307. - PMID 30844331

2

Subgroup Analysis : Refining a Positive Result or Trying to Rescue a Negative One?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Di Maio, M. | Perrone, F.

CommentOn: J Clin Oncol. 2015 May 20;33(15):1697-702. - PMID 25897150

3

Reply to P. Baldo et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Perrone, F. | Di Maio, M. | Gallo, C.

CommentOn: J Clin Oncol. 2015 Mar 10;33(8):910-5. - PMID 25624439

4

Adjuvant ovarian suppression in premenopausal breast cancer

enthalten in: The New England journal of medicine | 2015

von Montemurro, F. | Perrone, F. | Geuna, E.

CommentOn: N Engl J Med. 2015 Jan 29;372(5):436-46. - PMID 25495490

5

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer - authors' reply

enthalten in: The Lancet. Oncology | 2014

von Pignata, S. | Di Maio, M. | Gallo, C. | +1

CommentOn: Lancet Oncol. 2014 Jun;15(7):e249-50. - PMID 24872105

6

Reply to V. Lorusso et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Gridelli, C. | Gallo, C. | Butts, C. | +3

CommentOn: J Clin Oncol. 2012 Aug 20;30(24):3002-11. - PMID 22778317

7

Tackling off-label use of anticancer drugs

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Perrone, F. | de Braud, F. | Labianca, R. | +2

CommentOn: J Clin Oncol. 2012 Feb 20;30(6):661-6. - PMID 22253467

8

Zoledronic acid in early-stage breast cancer

enthalten in: The Lancet. Oncology | 2011

von Normanno, N. | De Luca, A. | Gallo, M. | +2

CommentOn: Lancet Oncol. 2011 Jul;12(7):631-41. - PMID 21641868

9

Trastuzumab beyond progression : is the risk of cardiac toxicity really not increased?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Morabito, A. | Piccirillo, M. | De Maio, E. | +2

CommentOn: J Clin Oncol. 2009 Apr 20;27(12):1999-2006. - PMID 19289619

10

Registrative trials of antiemetic drugs : arrival or starting point?

enthalten in: The Lancet. Oncology | 2009

von Di Maio, M. | Perrone, F.

CommentOn: Lancet Oncol. 2009 Jun;10(6):549-58. - PMID 19428297